Free Trial

NovoCure (NVCR) Competitors

$22.32
-0.83 (-3.59%)
(As of 05/28/2024 ET)

NVCR vs. ICUI, NARI, IART, IRTC, LMAT, TNDM, ATEC, AXNX, PRCT, and MDXG

Should you be buying NovoCure stock or one of its competitors? The main competitors of NovoCure include ICU Medical (ICUI), Inari Medical (NARI), Integra LifeSciences (IART), iRhythm Technologies (IRTC), LeMaitre Vascular (LMAT), Tandem Diabetes Care (TNDM), Alphatec (ATEC), Axonics (AXNX), PROCEPT BioRobotics (PRCT), and MiMedx Group (MDXG). These companies are all part of the "surgical & medical instruments" industry.

NovoCure vs.

ICU Medical (NASDAQ:ICUI) and NovoCure (NASDAQ:NVCR) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, community ranking, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 84.6% of NovoCure shares are held by institutional investors. 6.7% of ICU Medical shares are held by company insiders. Comparatively, 6.3% of NovoCure shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

NovoCure received 84 more outperform votes than ICU Medical when rated by MarketBeat users. However, 64.48% of users gave ICU Medical an outperform vote while only 63.71% of users gave NovoCure an outperform vote.

CompanyUnderperformOutperform
ICU MedicalOutperform Votes
383
64.48%
Underperform Votes
211
35.52%
NovoCureOutperform Votes
467
63.71%
Underperform Votes
266
36.29%

In the previous week, NovoCure had 2 more articles in the media than ICU Medical. MarketBeat recorded 8 mentions for NovoCure and 6 mentions for ICU Medical. NovoCure's average media sentiment score of 1.73 beat ICU Medical's score of 0.82 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
NovoCure
2 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

ICU Medical currently has a consensus price target of $123.00, indicating a potential upside of 17.25%. NovoCure has a consensus price target of $30.88, indicating a potential upside of 38.33%. Given ICU Medical's higher probable upside, analysts plainly believe NovoCure is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
NovoCure
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56

ICU Medical has a net margin of -2.63% compared to ICU Medical's net margin of -36.67%. NovoCure's return on equity of 5.38% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical-2.63% 5.38% 2.58%
NovoCure -36.67%-50.35%-16.86%

ICU Medical has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, NovoCure has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500.

ICU Medical has higher revenue and earnings than NovoCure. ICU Medical is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.26B1.13-$29.66M-$2.45-42.82
NovoCure$509.34M4.72-$207.04M-$1.81-12.33

Summary

ICU Medical beats NovoCure on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVCR vs. The Competition

MetricNovoCureSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.40B$3.87B$4.99B$8.09B
Dividend YieldN/A1.79%2.74%3.96%
P/E Ratio-12.3315.20175.1318.36
Price / Sales4.7274.452,498.8372.31
Price / CashN/A48.1532.9328.77
Price / Book6.584.254.944.39
Net Income-$207.04M$4.63M$104.17M$213.55M
7 Day Performance-1.89%-1.06%-0.65%-0.81%
1 Month Performance76.65%1.76%3.82%3.42%
1 Year Performance-69.66%17.39%5.45%7.52%

NovoCure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICUI
ICU Medical
4.0023 of 5 stars
$102.74
-0.5%
$123.00
+19.7%
-39.4%$2.50B$2.26B-41.9314,000Positive News
NARI
Inari Medical
3.2925 of 5 stars
$45.72
-0.9%
$65.71
+43.7%
-14.8%$2.66B$493.63M-111.511,300
IART
Integra LifeSciences
4.8471 of 5 stars
$27.38
+1.5%
$36.80
+34.4%
-24.9%$2.16B$1.53B54.763,946Positive News
Gap Up
High Trading Volume
IRTC
iRhythm Technologies
1.311 of 5 stars
$91.50
-1.2%
$134.00
+46.4%
-26.4%$2.85B$492.68M-21.632,000Positive News
LMAT
LeMaitre Vascular
3.2716 of 5 stars
$78.75
-0.8%
$73.83
-6.2%
+33.4%$1.77B$193.48M52.15614Positive News
TNDM
Tandem Diabetes Care
3.0621 of 5 stars
$49.32
+4.4%
$43.80
-11.2%
+99.1%$3.19B$747.72M-22.732,400Positive News
High Trading Volume
ATEC
Alphatec
4.5929 of 5 stars
$10.68
-3.2%
$22.89
+114.3%
-28.2%$1.54B$511.63M-7.17839Short Interest ↓
Positive News
AXNX
Axonics
2.6195 of 5 stars
$67.59
+0.1%
$70.73
+4.6%
+38.3%$3.45B$366.38M-211.22797Short Interest ↑
Positive News
PRCT
PROCEPT BioRobotics
1.1508 of 5 stars
$68.70
flat
$61.20
-10.9%
+102.4%$3.53B$156.33M-32.41626Positive News
MDXG
MiMedx Group
3.8593 of 5 stars
$7.95
-0.6%
$12.25
+54.1%
+30.2%$1.17B$321.48M18.07895Positive News

Related Companies and Tools

This page (NASDAQ:NVCR) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners